Pesquisas alternativas:
safety event » safety events (Expandir a Pesquisa)
event armed » prevent armed (Expandir a Pesquisa), events aimed (Expandir a Pesquisa), recent armed (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa)
case 1 » case _ (Expandir a Pesquisa)
safety event » safety events (Expandir a Pesquisa)
event armed » prevent armed (Expandir a Pesquisa), events aimed (Expandir a Pesquisa), recent armed (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa)
case 1 » case _ (Expandir a Pesquisa)
81
Por Siddiqui, Mohd Kashif, Shukla, Pragya, Jenkins, Martin, Ouwens, Mario, Guranlioglu, Deniz, Darken, Patrick, Biswas, Mousumi
Publicado no Ther Adv Respir Dis (2019)
“... and included at least one LAMA/LABA FDC or open LAMA + LABA treatment arm. NMAs were conducted for outcomes...”Publicado no Ther Adv Respir Dis (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
82
Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels...
Por Gianni, Luca, Lladó, Anna, Bianchi, Giulia, Cortes, Javier, Kellokumpu-Lehtinen, Pirkko-Liisa, Cameron, David A., Miles, David, Salvagni, Stefania, Wardley, Andrew, Goeminne, Jean-Charles, Hersberger, Veronica, Baselga, José
Publicado no J Clin Oncol (2010)
“... in eight patients, with one case of congestive heart failure in arm A. Pharmacokinetic data supported a...”Publicado no J Clin Oncol (2010)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
83
Por Jourdain, Gonzague, Ngo-Giang-Huong, Nicole, Cressey, Tim R., Hua, Lei, Harrison, Linda, Tierney, Camlin, Salvadori, Nicolas, Decker, Luc, Traisathit, Patrinee, Sirirungsi, Wasna, Khamduang, Woottichai, Bowonwatanuwong, Chureeratana, Puthanakit, Thanyawee, Siberry, George K., Watts, Diane Heather, Murphy, Trudy V., Achalapong, Jullapong, Hongsiriwon, Suchat, Klinbuayaem, Virat, Thongsawat, Satawat, Chung, Raymond T., Pol, Stanislas, Chotivanich, Nantasak
Publicado no BMC Infect Dis (2016)
“...-controlled, double-blind, randomized 1:1, two-arm clinical trial of TDF 300 mg once daily versus placebo...”Publicado no BMC Infect Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
84
Por Angelika Mahlknecht, Laura Krisch, Nadja Nestler, Ulrike Bauer, Nina Letz, Daniel Zenz, Jochen Schuler, Laura Fährmann, Georg Hempel, Maria Flamm, Jürgen Osterbrink
Publicado em 2019-09-01
Assuntos:
“...Drug safety...”Publicado em 2019-09-01
Obter o texto integral
Artigo
85
Por Kiyo Tanaka, Yasuhiro Nakamura, Tomonori Mizutani, Taro Shibata, Arata Tsutsumida, Haruhiko Fukuda, Shigeto Matsushita, Megumi Aoki, Kenjiro Namikawa, Shuichi Ohe, Satoshi Fukushima, Naoya Yamazaki, on behalf of the Dermatologic Oncology Group of the Japan Clinical Oncology Group
Publicado em 2019-10-01
Assuntos:
“...Single arm confirmatory trial...”Publicado em 2019-10-01
Obter o texto integral
Artigo
86
“... the efficacy of bevacizumab in brain tumor. On account of lack of vital information about safety events...”
Obter o texto integral
Obter o texto integral
Artigo
87
Por Steinberg, Gary K., Kondziolka, Douglas, Wechsler, Lawrence R., Lunsford, L. Dade, Coburn, Maria L., Billigen, Julia B., Kim, Anthony S., Johnson, Jeremiah N., Bates, Damien, King, Bill, Case, Casey, McGrogan, Michael, Yankee, Ernest W., Schwartz, Neil E.
Publicado no Stroke (2016)
“..., open-label, single-arm study to evaluate the safety and clinical outcomes of surgical transplantation...”Publicado no Stroke (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
88
Por Kunos, Charles A., Brindle, James, Waggoner, Steven, Zanotti, Kristine, Resnick, Kimberly, Fusco, Nancy, Adams, Ramon, Debernardo, Robert
Publicado em 2012
“... adverse events attributed to SBRT included fatigue (16%), nausea (8%), and diarrhea (4%). One (2%) grade...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
89
Por Mohammadian, R., Sharifipour, E., Mansourizadeh, R., Sohrabi, B., Nayebi, A.R, Haririan, S., Farhoudi, M., Charsouei, S., Najmi, S.
Publicado em 2013
“... and moderate stenosis that was treated medically, whereas one case (2.6%) with severe restenosis underwent...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
90
Publicado em 2006
“... assessment, data from 2 RCTs and 6 case series assessing the effectiveness and adverse events profile...”Obter o texto integral
Obter o texto integral
Artigo
91
Por Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
Publicado em 2022-04-01
“... of 210 RT-PCR-positive COVID-19 patients who provided consent were allotted to the control or case arm...”Publicado em 2022-04-01
Obter o texto integral
Artigo
92
Por Musa, Ahmed, Khalil, Eltahir, Hailu, Asrat, Olobo, Joseph, Balasegaram, Manica, Omollo, Raymond, Edwards, Tansy, Rashid, Juma, Mbui, Jane, Musa, Brima, Abuzaid, Abuzaid Abdalla, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Mueller, Marius, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Mutuma, Geoffrey, Apadet, Lilian, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tafes, Hailemariam, Mekonnen, Yalemtsehay, Makonnen, Eyasu, Ndegwa, Serah, Sagaki, Patrick, Kimutai, Robert, Kesusu, Josephine, Owiti, Rhoda, Ellis, Sally, Wasunna, Monique
Publicado em 2012
“... available for 359 patients per arm. In Intention-to-Treat complete-case analyses, the efficacy of PM...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
93
Por Padwal, Raj, McAlister, Finlay Aleck, Wood, Peter William, Boulanger, Pierre, Fradette, Miriam, Klarenbach, Scott, Edwards, Alun L, Holroyd-Leduc, Jayna M, Alagiakrishnan, Kannayiram, Rabi, Doreen, Majumdar, Sumit Ranjan
Publicado no JMIR Res Protoc (2016)
“..., with or without protocolized case management. OBJECTIVE: To examine the incremental effectiveness, safety, cost...”Publicado no JMIR Res Protoc (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
94
95
Por Peckham, Emily J, Cooper, Katy, Roberts, E Rachel, Agrawal, Anurag, Brabyn, Sally, Tew, Garry
Publicado no Cochrane Database Syst Rev (2019)
“... in the placebo arm experienced a global improvement in symptoms (RR 1.31, 95% CI 0.80 to 2.15; very low certainty...”Publicado no Cochrane Database Syst Rev (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
96
Por Criner, Gerard J., Delage, Antoine, Voelker, Kirk, Hogarth, D. Kyle, Majid, Adnan, Zgoda, Michael, Lazarus, Donald R., Casal, Roberto, Benzaquen, Sadia B., Holladay, Robert C., Wellikoff, Adam, Calero, Karel, Rumbak, Mark J., Branca, Paul R., Abu-Hijleh, Muhanned, Mallea, Jorge M., Kalhan, Ravi, Sachdeva, Ashutosh, Kinsey, C. Matthew, Lamb, Carla R., Reed, Michael F., Abouzgheib, Wissam B., Kaplan, Phillip V., Marrujo, Gregory X., Johnstone, David W., Gasparri, Mario G., Meade, Arturo A., Hergott, Christopher A., Reddy, Chakravarthy, Mularski, Richard A., Case, Amy Hajari, Makani, Samir S., Shepherd, Ray W., Chen, Benson, Holt, Gregory E.
Publicado no Am J Respir Crit Care Med (2019)
“... with severe, heterogeneous emphysema were randomized 2:1 to SVS with medical management (treatment) or medical...”Publicado no Am J Respir Crit Care Med (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
97
Por Matthew Chinman, Walid F. Gellad, Sharon McCarthy, Adam J. Gordon, Shari Rogal, Maria K. Mor, Leslie R. M. Hausmann
Publicado em 2019-01-01
“... for patients whom STORM identifies as very high-risk (i.e., top 1% of STORM risk scores). Half of VAMCs were...”Publicado em 2019-01-01
Obter o texto integral
Artigo
98
Por Holodniy, Mark, Penzak, Scott R., Straight, Timothy M., Davey, Richard T., Lee, Kelvin K., Goetz, Matthew Bidwell, Raisch, Dennis W., Cunningham, Francesca, Lin, Emil T., Olivo, Noemi, Deyton, Lawrence R.
Publicado em 2008
“... tolerated, except for one case of reversible grade 4 thrombocytopenia in a subject in group 2...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
99
Por Moy, Beverly, Neven, Patrick, Lebrun, Fabienne, Bellet, Meritxell, Xu, Binghe, Sarosiek, Tomasz, Chow, Louis, Goss, Paul, Zacharchuk, Charles, Leip, Eric, Turnbull, Kathleen, Bardy-Bouxin, Nathalie, Duvillié, Ladan, Láng, István
Publicado em 2014
“.... In the single-arm safety/dose-confirming lead-in (part 1), patients received oral bosutinib at 400 mg/day plus...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
100
Por Källander, Karin, Alfven, Tobias, Workineh, Ayalkibet Abebe, Hailemariam,, Abreham, Petzold, Max, Getachew, Dawit, Barat, Lawrence, Steinhardt, Laura C, Gutman, Julie R
Publicado no JMIR Res Protoc (2018)
“... are randomized to one of the 2 intervention arms; all 144 health posts and 284 community health workers...”Publicado no JMIR Res Protoc (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo